Abstract:AIM:To study Hepatitis B virus (HBV) infection and its association with hepatocellular carcinoma (HCC) at the miRNA level.METHODS:Three cellular models were used to investigate miRNA expression changes during HBV infection: human HepG2 hepatoblastoma cell line as a model without HBV infection; HepG2 cell line transfected with a 1.3-fold full-length HBV genome as an acute infection model; and HepG2.2.15 cell line, which is derived from HepG2 and stably transfected with a complete HBV genome, as a chronic infection model. The miRNA levels were examined using microarray technology. To explore the relationship between HBV infection and HCC genesis at the miRNA level, we downloaded from national center for biotechnology information Gene Expression Omnibus an miRNA expression dataset derived from HCC patients, most of whom are HBV carriers. We compared the miRNA expression alterations during HBV infection with those in HCC patients, by analyzing miRNA expression change profiles statistically.RESULTS:Seventy-seven and 48 miRNAs were differentially expressed during acute and chronic HBV infection, respectively. Among these miRNAs, 25 were in common, the intersection of which was significant under the hypergeometric test (P = 1.3 × 10⁻¹¹). Fourteen miRNAs were observed to change coherently in the acute and chronic infections, with one upregulated and 13 downregulated. Eleven showed inverse changes during the two phases of infection; downregulated in the acute infection and upregulated in the chronic infection. The results imply that common and specific mechanisms exist at the miRNA level during acute and chronic HBV infection. Besides, comparative analysis of the miRNA expression changes during HBV infection with those in HCC indicates that, although miRNA expression changes during HBV infection are distinct from those in HCC patients (P < 2.2 × 10⁻¹⁶), they exhibited significant correlations (P = 0.0229 for acute infection; P = 0.0084 for chronic infection). Perturbation of miRNA expression during chronic HBV infection was closer to that in HCC patients than that during acute HBV infection. This observation implies the contribution of miRNAs to HCC genesis from HBV infection. According to their patterns of differential expression in acute and chronic HBV infection, as well as in HCC, miRNAs of potential research interest could be identified, such as miR-18a/miR-18b, miR-106a, miR-221 and miR-101. For instance, the gradient expression alteration of miR-221 in the above three phases, which is downregulated in acute HBV infection, normally expressed in chronic HBV infection, and upregulated in HCC, indicates that it may be a key effector for progression of the disease.CONCLUSION:Our analysis provides insights into HBV infection and related HCC in relation to miRNAs, and reveals some candidate miRNAs for future studies.

Deregulation of Microrna Expression Occurs Early and Accumulates in Early Stages of HBV-associated Multistep Hepatocarcinogenesis

MicroRNA Profile in HBV-induced Infection and Hepatocellular Carcinoma.

MicroRNA-302d Downregulates TGFBR2 Expression and Promotes Hepatocellular Carcinoma Growth and Invasion.

Dysregulated Micrornas in Hepatitis B Virus-Related Hepatocellular Carcinoma: Potential As Biomarkers and Therapeutic Targets

MicroRNAs in Hepatocellular Carcinoma: Regulation, Function, and Clinical Implications

Hepatitis B Virus and Hepatocellular Carcinoma at the Mirna Level.

The Regulatory Role of MicroRNA in Hepatitis-B Virus-Associated Hepatocellular Carcinoma (HBV-HCC) Pathogenesis

Identification of Deregulated Mirnas and Their Targets in Hepatitis B Virus-Associated Hepatocellular Carcinoma

Cross-regulation Between Micrornas and Key Proteins of Signaling Pathways in Hepatocellular Carcinoma

Dysregulated microRNAs as a biomarker for diagnosis and prognosis of hepatitis B virus-associated hepatocellular carcinoma

Aberrant expression of two miRNAs promotes proliferation, hepatitis B virus amplification, migration and invasion of hepatocellular carcinoma cells: evidence from bioinformatic analysis and experimental validation

Microrna-602 Regulating Tumor Suppressive Gene Rassf1a is Overexpressed in Hepatitis B Virus-Infected Liver and Hepatocellular Carcinoma

Potential Microrna Panel For The Diagnosis And Prediction Of Overall Survival Of Hepatocellular Carcinoma With Hepatitis B Virus Infection

MicroRNAs Associated with HBV Infection and HBV-related HCC.

Functional Analysis of Mir-767-5p During the Progression of Hepatocellular Carcinoma and the Clinical Relevance of Its Dysregulation

Advances in research on the role and mechanism of microRNAs in hepatic carcinogenesis

Hepatitis C Virus-Induced Up-Regulation of Microrna-155 Promotes Hepatocarcinogenesis by Activating Wnt Signaling.

Expression of the Microrna-143/145 Cluster is Decreased in Hepatitis B Virus-Associated Hepatocellular Carcinoma and May Serve As a Biomarker for Tumorigenesis in Patients with Chronic Hepatitis B

Systematic integration of molecular and clinical approaches in HCV-induced hepatocellular carcinoma

Up-regulated MicroRNA-181a Induces Carcinogenesis in Hepatitis B Virus-Related Hepatocellular Carcinoma by Targeting E2F5

Identification of potential miRNA–mRNA regulatory network contributing to pathogenesis of HBV-related HCC